ScienceCLAW Information Extraction
Extract structured information from scientific texts including named entities, relations, data tables, methods, results, and experimental parameters.
When to Use
Use this skill when the user:
- Needs to parse a scientific paper for key data points (measurements, parameters, outcomes)
- Wants to extract experimental methods, conditions, or protocols from a paper
- Needs named entity recognition (NER) on scientific documents (chemicals, genes, diseases, etc.)
- Wants to build a knowledge graph or structured database from literature
- Needs to extract relations between scientific entities (drug-target, gene-disease, cause-effect)
- Wants structured tables from unstructured scientific text
- Needs to compare methods or results across multiple papers in a structured format
- Wants to extract metadata from papers (authors, affiliations, funding, conflicts of interest)
When NOT to Use
Do not use this skill when:
- The user wants a narrative summary of a paper (use scienceclaw-summarization)
- The user needs to find and retrieve papers (use scienceclaw-retrieval)
- The user wants to answer a scientific question (use scienceclaw-qa)
- The user needs multi-step reasoning or proof construction (use scienceclaw-reasoning)
- The user needs code-based data analysis (use code-execution)
Entity Types by Discipline
Biomedical Sciences
| Entity Type |
Examples |
Common Formats |
| Gene/Protein |
TP53, BRCA1, insulin |
Uppercase symbols, UniProt IDs |
| Disease |
Type 2 diabetes, glioblastoma |
MeSH terms, ICD codes |
| Drug/Chemical |
Metformin, aspirin, NaCl |
IUPAC names, brand names, CAS numbers |
| Organism |
Homo sapiens, E. coli |
Binomial nomenclature, NCBI Taxonomy ID |
| Cell Line |
HeLa, HEK293T |
ATCC identifiers |
| Anatomical Structure |
hippocampus, mitochondria |
UBERON ontology terms |
| Biological Process |
apoptosis, glycolysis |
GO terms |
| Dosage |
10 mg/kg, 500 nM |
Value + unit patterns |
| Biomarker |
HbA1c, PSA, CRP |
Abbreviations with reference ranges |
Chemistry and Materials Science
| Entity Type |
Examples |
Common Formats |
| Chemical Compound |
benzene, polyethylene glycol |
IUPAC, SMILES, InChI |
| Material |
graphene, Ti-6Al-4V, PDMS |
Common names, composition formulas |
| Property |
melting point, band gap, tensile strength |
Property name + value + unit |
| Synthesis Method |
sol-gel, CVD, electrospinning |
Method name + parameters |
| Characterization Technique |
XRD, SEM, NMR, FTIR |
Acronyms with parameters |
| Crystal Structure |
FCC, BCC, hexagonal |
Space group, lattice parameters |
| Catalyst |
Pd/C, TiO2, zeolite |
Composition + support |
Physics and Astronomy
| Entity Type |
Examples |
Common Formats |
| Physical Quantity |
3.14 eV, 300 K, 1.5 T |
Value + SI/derived unit |
| Particle |
electron, muon, Higgs boson |
Standard Model names |
| Astronomical Object |
NGC 1277, Proxima Centauri |
Catalog designations |
| Physical Constant |
c, h, G, k_B |
Symbol + numerical value + unit |
| Equation/Law |
Schrodinger equation, F = ma |
Named equations, formulas |
| Experimental Apparatus |
LHC, LIGO, HST |
Acronyms and facility names |
| Measurement Technique |
spectroscopy, interferometry |
Technique name + configuration |
Social Sciences
| Entity Type |
Examples |
Common Formats |
| Study Design |
RCT, cohort study, survey |
Methodology descriptors |
| Statistical Measure |
p = 0.03, r = 0.45, d = 0.8 |
Statistic symbol + value |
| Sample |
N = 1,200 adults aged 18-65 |
Size + demographic descriptors |
| Instrument/Scale |
Likert scale, BDI-II, MMSE |
Named instruments with citations |
| Effect |
income inequality, voter turnout |
Outcome variable descriptions |
| Theory/Framework |
rational choice, social learning |
Named theoretical frameworks |
| Policy/Intervention |
minimum wage increase, CBT |
Intervention descriptions |
| Geographic Scope |
United States, OECD countries |
Country/region names |
| Time Period |
2010-2020, post-WWII |
Date ranges, era references |
Computer Science
| Entity Type |
Examples |
Common Formats |
| Algorithm |
Adam optimizer, BERT, ResNet-50 |
Named algorithms with versions |
| Dataset |
ImageNet, MNIST, GLUE |
Named benchmarks |
| Metric |
F1 = 0.92, accuracy = 95.3%, BLEU = 32.1 |
Metric name + value |
| Architecture |
transformer, CNN, GAN |
Architecture type names |
| Hyperparameter |
learning rate = 1e-4, batch size = 32 |
Parameter name + value |
| Framework/Library |
PyTorch, TensorFlow, scikit-learn |
Software names with versions |
| Hardware |
A100 GPU, TPU v4 |
Hardware specifications |
Relation Schemas
Core Relation Types
| Relation |
Description |
Example |
| TREATS |
Drug/intervention treats disease |
(Metformin, TREATS, Type 2 diabetes) |
| CAUSES |
Agent causes effect |
(Smoking, CAUSES, Lung cancer) |
| INHIBITS |
Entity inhibits another |
(Aspirin, INHIBITS, COX-2) |
| ACTIVATES |
Entity activates another |
(EGF, ACTIVATES, EGFR) |
| PART_OF |
Component is part of whole |
(Hippocampus, PART_OF, Limbic system) |
| MEASURED_BY |
Property measured by technique |
(Crystal structure, MEASURED_BY, XRD) |
| SYNTHESIZED_VIA |
Material made by method |
(Graphene, SYNTHESIZED_VIA, CVD) |
| ASSOCIATED_WITH |
Statistical association |
(Gene X, ASSOCIATED_WITH, Disease Y) |
| OUTPERFORMS |
Method A outperforms B |
(BERT, OUTPERFORMS, LSTM on GLUE) |
| DERIVED_FROM |
Result derived from data/method |
(Estimate, DERIVED_FROM, Meta-analysis) |
| USED_IN |
Tool/method used in study |
(fMRI, USED_IN, Smith et al. 2023) |
| CONTRADICTS |
Finding contradicts another |
(Study A, CONTRADICTS, Study B) |
| SUPPORTS |
Finding supports another |
(Experiment, SUPPORTS, Hypothesis) |
Relation Attributes
Each extracted relation should include:
- Source: The text span or sentence from which the relation was extracted
- Confidence: High / Medium / Low based on explicitness of the statement
- Direction: Whether the relation is directional or bidirectional
- Qualifier: Any conditions or modifiers (e.g., "in vitro", "at high doses", "in Western populations")
- Evidence type: Direct statement, implication, or inference
Output Formats
JSON Output
For programmatic consumption and knowledge graph construction:
{
"document": {
"title": "Paper title",
"doi": "10.xxxx/xxxxx",
"authors": ["Author A", "Author B"]
},
"entities": [
{
"id": "E1",
"text": "metformin",
"type": "Drug",
"normalized": "CHEMBL1431",
"spans": [{"start": 145, "end": 154}]
}
],
"relations": [
{
"id": "R1",
"type": "TREATS",
"subject": "E1",
"object": "E2",
"confidence": "high",
"qualifier": "first-line therapy",
"source_sentence": "Metformin is the first-line therapy for T2D."
}
],
"extracted_data": {
"methods": {},
"results": {},
"parameters": {}
}
}
Markdown Table Output
For human-readable structured summaries:
| Parameter | Value | Unit | Conditions | Source (Section) |
|---|---|---|---|---|
| Temperature | 350 | C | Under N2 atmosphere | Methods 2.3 |
| Pressure | 1.5 | atm | At steady state | Methods 2.3 |
| Yield | 87.3 | % | After 24h reaction | Results 3.1 |
Knowledge Graph Triples
For direct ingestion into graph databases:
(Metformin)-[TREATS {confidence: high}]->(Type 2 Diabetes)
(Metformin)-[INHIBITS {confidence: high}]->(Hepatic Gluconeogenesis)
(Metformin)-[ACTIVATES {confidence: medium}]->(AMPK)
Extraction Templates
Experimental Methods Extraction
Extract the following from methods sections:
methods:
study_design: [RCT | cohort | case-control | cross-sectional | in vitro | in vivo | simulation]
sample:
size: [N]
description: [population/material description]
inclusion_criteria: [list]
exclusion_criteria: [list]
intervention:
name: [intervention name]
dose: [dose with units]
duration: [time period]
route: [administration route]
control:
type: [placebo | active comparator | no treatment | baseline]
description: [control description]
measurements:
primary_outcome: [outcome measure]
secondary_outcomes: [list]
instruments: [measurement tools/techniques]
timepoints: [when measured]
statistical_analysis:
methods: [t-test, ANOVA, regression, etc.]
software: [R, SPSS, Python, etc.]
significance_threshold: [alpha level]
Results Extraction
Extract quantitative results in structured form:
results:
primary_outcome:
measure: [outcome name]
treatment_group: [value +/- SD or 95% CI]
control_group: [value +/- SD or 95% CI]
effect_size: [value with CI]
p_value: [value]
significance: [significant | not significant]
secondary_outcomes:
- measure: [name]
value: [result]
p_value: [value]
adverse_events:
- event: [description]
frequency: [n/N or percentage]
severity: [mild | moderate | severe]
key_figures:
- figure_number: [Fig. N]
description: [what is shown]
key_finding: [main takeaway]
key_tables:
- table_number: [Table N]
description: [what is tabulated]
key_values: [most important entries]
Paper Metadata Extraction
metadata:
title: [full title]
authors: [list with affiliations]
journal: [journal name]
year: [publication year]
doi: [DOI]
keywords: [author keywords]
abstract_summary: [one-sentence summary]
study_type: [primary research | review | meta-analysis | case report | editorial]
funding: [funding sources]
conflicts: [declared conflicts of interest]
data_availability: [statement about data sharing]
code_availability: [statement about code sharing]
Extraction Quality Guidelines
Accuracy Standards
- Extract only information explicitly stated in the text (do not infer or hallucinate)
- Preserve exact numerical values including units and uncertainty
- Flag ambiguous extractions with a confidence indicator
- When multiple interpretations are possible, extract all with annotations
- Distinguish between author claims and independently verified facts
Completeness Standards
- Extract all instances of the target entity/relation type in the document
- Cover all relevant sections (abstract, introduction, methods, results, discussion, supplementary)
- Note when information is missing or not reported ("NR" = not reported)
- Flag when the text references supplementary materials not included in the extraction scope
Normalization Standards
- Normalize entity names to canonical forms where possible (e.g., gene symbols to HGNC)
- Convert units to SI when practical, noting the original units
- Resolve abbreviations to full forms on first occurrence
- Link entities to standard identifiers (DOI, PubChem CID, UniProt ID, etc.) when identifiable
Multi-Document Extraction
When extracting from multiple papers for comparison:
- Align schemas: Use consistent entity types and relation schemas across all documents
- Create comparison tables: Organize results in parallel columns by study
- Flag contradictions: Highlight where different papers report conflicting values or conclusions
- Aggregate where appropriate: Compute ranges, means, or consensus values across studies
- Track provenance: Every extracted value must be traceable to its source document and section
Integration with Other Skills
- scienceclaw-retrieval: Retrieve papers that serve as input for extraction
- scienceclaw-qa: Provide extracted data as evidence for answering questions
- scienceclaw-reasoning: Supply extracted premises and data for reasoning chains
- code-execution: Post-process extracted data (statistics, visualization, database loading)
- scienceclaw-summarization: Extraction provides structured input; summarization provides narrative output
Zero-Hallucination Rule
ALL factual claims, citations, database results, and scientific data presented to the user MUST come from actual tool results (API calls, code execution, web search) in this conversation. NEVER fabricate or "fill in" details from training data. If a tool returns no results or partial data, report exactly what happened.
1---2name: scienceclaw-ie3description: Extract structured information from scientific texts: entities, relations, data tables, methods, results. Use when: (1) parsing papers for key data, (2) extracting experimental parameters, (3) building knowledge graphs from literature, (4) NER on scientific documents, (5) extracting methods/results sections. NOT for: summarization (use scienceclaw-summarization), full text retrieval (use scienceclaw-retrieval).4---5
6# ScienceCLAW Information Extraction
7
8Extract structured information from scientific texts including named entities, relations, data tables, methods, results, and experimental parameters.
9
10## When to Use
11
12Use this skill when the user:
13
14- Needs to parse a scientific paper for key data points (measurements, parameters, outcomes)
15- Wants to extract experimental methods, conditions, or protocols from a paper
16- Needs named entity recognition (NER) on scientific documents (chemicals, genes, diseases, etc.)
17- Wants to build a knowledge graph or structured database from literature
18- Needs to extract relations between scientific entities (drug-target, gene-disease, cause-effect)
19- Wants structured tables from unstructured scientific text
20- Needs to compare methods or results across multiple papers in a structured format
21- Wants to extract metadata from papers (authors, affiliations, funding, conflicts of interest)
22
23## When NOT to Use
24
25Do not use this skill when:
26
27- The user wants a narrative summary of a paper (use scienceclaw-summarization)
28- The user needs to find and retrieve papers (use scienceclaw-retrieval)
29- The user wants to answer a scientific question (use scienceclaw-qa)
30- The user needs multi-step reasoning or proof construction (use scienceclaw-reasoning)
31- The user needs code-based data analysis (use code-execution)
32
33## Entity Types by Discipline
34
35### Biomedical Sciences
36
37| Entity Type | Examples | Common Formats |
38|---|---|---|
39| Gene/Protein | TP53, BRCA1, insulin | Uppercase symbols, UniProt IDs |
40| Disease | Type 2 diabetes, glioblastoma | MeSH terms, ICD codes |
41| Drug/Chemical | Metformin, aspirin, NaCl | IUPAC names, brand names, CAS numbers |
42| Organism | Homo sapiens, E. coli | Binomial nomenclature, NCBI Taxonomy ID |
43| Cell Line | HeLa, HEK293T | ATCC identifiers |
44| Anatomical Structure | hippocampus, mitochondria | UBERON ontology terms |
45| Biological Process | apoptosis, glycolysis | GO terms |
46| Dosage | 10 mg/kg, 500 nM | Value + unit patterns |
47| Biomarker | HbA1c, PSA, CRP | Abbreviations with reference ranges |
48
49### Chemistry and Materials Science
50
51| Entity Type | Examples | Common Formats |
52|---|---|---|
53| Chemical Compound | benzene, polyethylene glycol | IUPAC, SMILES, InChI |
54| Material | graphene, Ti-6Al-4V, PDMS | Common names, composition formulas |
55| Property | melting point, band gap, tensile strength | Property name + value + unit |
56| Synthesis Method | sol-gel, CVD, electrospinning | Method name + parameters |
57| Characterization Technique | XRD, SEM, NMR, FTIR | Acronyms with parameters |
58| Crystal Structure | FCC, BCC, hexagonal | Space group, lattice parameters |
59| Catalyst | Pd/C, TiO2, zeolite | Composition + support |
60
61### Physics and Astronomy
62
63| Entity Type | Examples | Common Formats |
64|---|---|---|
65| Physical Quantity | 3.14 eV, 300 K, 1.5 T | Value + SI/derived unit |
66| Particle | electron, muon, Higgs boson | Standard Model names |
67| Astronomical Object | NGC 1277, Proxima Centauri | Catalog designations |
68| Physical Constant | c, h, G, k_B | Symbol + numerical value + unit |
69| Equation/Law | Schrodinger equation, F = ma | Named equations, formulas |
70| Experimental Apparatus | LHC, LIGO, HST | Acronyms and facility names |
71| Measurement Technique | spectroscopy, interferometry | Technique name + configuration |
72
73### Social Sciences
74
75| Entity Type | Examples | Common Formats |
76|---|---|---|
77| Study Design | RCT, cohort study, survey | Methodology descriptors |
78| Statistical Measure | p = 0.03, r = 0.45, d = 0.8 | Statistic symbol + value |
79| Sample | N = 1,200 adults aged 18-65 | Size + demographic descriptors |
80| Instrument/Scale | Likert scale, BDI-II, MMSE | Named instruments with citations |
81| Effect | income inequality, voter turnout | Outcome variable descriptions |
82| Theory/Framework | rational choice, social learning | Named theoretical frameworks |
83| Policy/Intervention | minimum wage increase, CBT | Intervention descriptions |
84| Geographic Scope | United States, OECD countries | Country/region names |
85| Time Period | 2010-2020, post-WWII | Date ranges, era references |
86
87### Computer Science
88
89| Entity Type | Examples | Common Formats |
90|---|---|---|
91| Algorithm | Adam optimizer, BERT, ResNet-50 | Named algorithms with versions |
92| Dataset | ImageNet, MNIST, GLUE | Named benchmarks |
93| Metric | F1 = 0.92, accuracy = 95.3%, BLEU = 32.1 | Metric name + value |
94| Architecture | transformer, CNN, GAN | Architecture type names |
95| Hyperparameter | learning rate = 1e-4, batch size = 32 | Parameter name + value |
96| Framework/Library | PyTorch, TensorFlow, scikit-learn | Software names with versions |
97| Hardware | A100 GPU, TPU v4 | Hardware specifications |
98
99## Relation Schemas
100
101### Core Relation Types
102
103| Relation | Description | Example |
104|---|---|---|
105| TREATS | Drug/intervention treats disease | (Metformin, TREATS, Type 2 diabetes) |
106| CAUSES | Agent causes effect | (Smoking, CAUSES, Lung cancer) |
107| INHIBITS | Entity inhibits another | (Aspirin, INHIBITS, COX-2) |
108| ACTIVATES | Entity activates another | (EGF, ACTIVATES, EGFR) |
109| PART_OF | Component is part of whole | (Hippocampus, PART_OF, Limbic system) |
110| MEASURED_BY | Property measured by technique | (Crystal structure, MEASURED_BY, XRD) |
111| SYNTHESIZED_VIA | Material made by method | (Graphene, SYNTHESIZED_VIA, CVD) |
112| ASSOCIATED_WITH | Statistical association | (Gene X, ASSOCIATED_WITH, Disease Y) |
113| OUTPERFORMS | Method A outperforms B | (BERT, OUTPERFORMS, LSTM on GLUE) |
114| DERIVED_FROM | Result derived from data/method | (Estimate, DERIVED_FROM, Meta-analysis) |
115| USED_IN | Tool/method used in study | (fMRI, USED_IN, Smith et al. 2023) |
116| CONTRADICTS | Finding contradicts another | (Study A, CONTRADICTS, Study B) |
117| SUPPORTS | Finding supports another | (Experiment, SUPPORTS, Hypothesis) |
118
119### Relation Attributes
120
121Each extracted relation should include:
122
123- **Source**: The text span or sentence from which the relation was extracted
124- **Confidence**: High / Medium / Low based on explicitness of the statement
125- **Direction**: Whether the relation is directional or bidirectional
126- **Qualifier**: Any conditions or modifiers (e.g., "in vitro", "at high doses", "in Western populations")
127- **Evidence type**: Direct statement, implication, or inference
128
129## Output Formats
130
131### JSON Output
132
133For programmatic consumption and knowledge graph construction:
134
135```json
136{
137 "document": {
138 "title": "Paper title",
139 "doi": "10.xxxx/xxxxx",
140 "authors": ["Author A", "Author B"]
141 },
142 "entities": [
143 {
144 "id": "E1",
145 "text": "metformin",
146 "type": "Drug",
147 "normalized": "CHEMBL1431",
148 "spans": [{"start": 145, "end": 154}]
149 }
150 ],
151 "relations": [
152 {
153 "id": "R1",
154 "type": "TREATS",
155 "subject": "E1",
156 "object": "E2",
157 "confidence": "high",
158 "qualifier": "first-line therapy",
159 "source_sentence": "Metformin is the first-line therapy for T2D."
160 }
161 ],
162 "extracted_data": {
163 "methods": {},
164 "results": {},
165 "parameters": {}
166 }
167}
168```
169
170### Markdown Table Output
171
172For human-readable structured summaries:
173
174```markdown
175| Parameter | Value | Unit | Conditions | Source (Section) |
176|---|---|---|---|---|
177| Temperature | 350 | C | Under N2 atmosphere | Methods 2.3 |
178| Pressure | 1.5 | atm | At steady state | Methods 2.3 |
179| Yield | 87.3 | % | After 24h reaction | Results 3.1 |
180```
181
182### Knowledge Graph Triples
183
184For direct ingestion into graph databases:
185
186```
187(Metformin)-[TREATS {confidence: high}]->(Type 2 Diabetes)
188(Metformin)-[INHIBITS {confidence: high}]->(Hepatic Gluconeogenesis)
189(Metformin)-[ACTIVATES {confidence: medium}]->(AMPK)
190```
191
192## Extraction Templates
193
194### Experimental Methods Extraction
195
196Extract the following from methods sections:
197
198```yaml
199methods:
200 study_design: [RCT | cohort | case-control | cross-sectional | in vitro | in vivo | simulation]
201 sample:
202 size: [N]
203 description: [population/material description]
204 inclusion_criteria: [list]
205 exclusion_criteria: [list]
206 intervention:
207 name: [intervention name]
208 dose: [dose with units]
209 duration: [time period]
210 route: [administration route]
211 control:
212 type: [placebo | active comparator | no treatment | baseline]
213 description: [control description]
214 measurements:
215 primary_outcome: [outcome measure]
216 secondary_outcomes: [list]
217 instruments: [measurement tools/techniques]
218 timepoints: [when measured]
219 statistical_analysis:
220 methods: [t-test, ANOVA, regression, etc.]
221 software: [R, SPSS, Python, etc.]
222 significance_threshold: [alpha level]
223```
224
225### Results Extraction
226
227Extract quantitative results in structured form:
228
229```yaml
230results:
231 primary_outcome:
232 measure: [outcome name]
233 treatment_group: [value +/- SD or 95% CI]
234 control_group: [value +/- SD or 95% CI]
235 effect_size: [value with CI]
236 p_value: [value]
237 significance: [significant | not significant]
238 secondary_outcomes:
239 - measure: [name]
240 value: [result]
241 p_value: [value]
242 adverse_events:
243 - event: [description]
244 frequency: [n/N or percentage]
245 severity: [mild | moderate | severe]
246 key_figures:
247 - figure_number: [Fig. N]
248 description: [what is shown]
249 key_finding: [main takeaway]
250 key_tables:
251 - table_number: [Table N]
252 description: [what is tabulated]
253 key_values: [most important entries]
254```
255
256### Paper Metadata Extraction
257
258```yaml
259metadata:
260 title: [full title]
261 authors: [list with affiliations]
262 journal: [journal name]
263 year: [publication year]
264 doi: [DOI]
265 keywords: [author keywords]
266 abstract_summary: [one-sentence summary]
267 study_type: [primary research | review | meta-analysis | case report | editorial]
268 funding: [funding sources]
269 conflicts: [declared conflicts of interest]
270 data_availability: [statement about data sharing]
271 code_availability: [statement about code sharing]
272```
273
274## Extraction Quality Guidelines
275
276### Accuracy Standards
277
278- Extract only information explicitly stated in the text (do not infer or hallucinate)
279- Preserve exact numerical values including units and uncertainty
280- Flag ambiguous extractions with a confidence indicator
281- When multiple interpretations are possible, extract all with annotations
282- Distinguish between author claims and independently verified facts
283
284### Completeness Standards
285
286- Extract all instances of the target entity/relation type in the document
287- Cover all relevant sections (abstract, introduction, methods, results, discussion, supplementary)
288- Note when information is missing or not reported ("NR" = not reported)
289- Flag when the text references supplementary materials not included in the extraction scope
290
291### Normalization Standards
292
293- Normalize entity names to canonical forms where possible (e.g., gene symbols to HGNC)
294- Convert units to SI when practical, noting the original units
295- Resolve abbreviations to full forms on first occurrence
296- Link entities to standard identifiers (DOI, PubChem CID, UniProt ID, etc.) when identifiable
297
298## Multi-Document Extraction
299
300When extracting from multiple papers for comparison:
301
3021. **Align schemas**: Use consistent entity types and relation schemas across all documents
3032. **Create comparison tables**: Organize results in parallel columns by study
3043. **Flag contradictions**: Highlight where different papers report conflicting values or conclusions
3054. **Aggregate where appropriate**: Compute ranges, means, or consensus values across studies
3065. **Track provenance**: Every extracted value must be traceable to its source document and section
307
308## Integration with Other Skills
309
310- **scienceclaw-retrieval**: Retrieve papers that serve as input for extraction
311- **scienceclaw-qa**: Provide extracted data as evidence for answering questions
312- **scienceclaw-reasoning**: Supply extracted premises and data for reasoning chains
313- **code-execution**: Post-process extracted data (statistics, visualization, database loading)
314- **scienceclaw-summarization**: Extraction provides structured input; summarization provides narrative output
315
316## Zero-Hallucination Rule
317
318ALL factual claims, citations, database results, and scientific data presented to the user MUST come from actual tool results (API calls, code execution, web search) in this conversation. NEVER fabricate or "fill in" details from training data. If a tool returns no results or partial data, report exactly what happened.